Frank Spillmann

4.9k total citations · 1 hit paper
68 papers, 3.5k citations indexed

About

Frank Spillmann is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Genetics. According to data from OpenAlex, Frank Spillmann has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 27 papers in Surgery and 16 papers in Genetics. Recurrent topics in Frank Spillmann's work include Cardiac Structural Anomalies and Repair (15 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Cardiovascular Function and Risk Factors (11 papers). Frank Spillmann is often cited by papers focused on Cardiac Structural Anomalies and Repair (15 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Cardiovascular Function and Risk Factors (11 papers). Frank Spillmann collaborates with scholars based in Germany, United States and Italy. Frank Spillmann's co-authors include Carsten Tschöpe, Sophie Van Linthout, Dirk Westermann, Heinz‐Peter Schultheiss, Heinz‐Peter Schultheiß, Michel Noutsias, Marco Meloni, Alexander Riad, Thomas Walther and Felicitas Escher and has published in prestigious journals such as Circulation, Circulation Research and Diabetes.

In The Last Decade

Frank Spillmann

64 papers receiving 3.5k citations

Hit Papers

Myocarditis and inflammatory cardiomyopathy: current evid... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Spillmann Germany 32 2.2k 881 824 337 320 68 3.5k
A. Koneti Rao United States 41 1.7k 0.8× 697 0.8× 1.2k 1.5× 425 1.3× 886 2.8× 147 5.5k
Marc R. Barnard United States 32 1.9k 0.9× 326 0.4× 845 1.0× 226 0.7× 232 0.7× 59 4.4k
Domenico Corradi Italy 34 2.3k 1.1× 747 0.8× 1.8k 2.2× 300 0.9× 222 0.7× 128 5.5k
Martin G. Sirois Canada 38 1.2k 0.6× 1.6k 1.8× 564 0.7× 227 0.7× 147 0.5× 125 4.0k
Daiju Fukuda Japan 35 1.8k 0.8× 867 1.0× 1.6k 1.9× 301 0.9× 91 0.3× 92 4.0k
Hideshi Okada Japan 27 1.1k 0.5× 943 1.1× 531 0.6× 115 0.3× 118 0.4× 120 2.7k
Mark I. Furman United States 31 2.3k 1.1× 360 0.4× 912 1.1× 226 0.7× 157 0.5× 50 4.3k
Manuel Galiñanes United Kingdom 33 1.2k 0.5× 842 1.0× 1.2k 1.4× 69 0.2× 362 1.1× 127 3.2k
Yunzeng Zou China 28 1.0k 0.5× 712 0.8× 514 0.6× 239 0.7× 252 0.8× 94 2.1k
Kimihiro Komori Japan 34 1.2k 0.6× 1.2k 1.4× 1.8k 2.2× 254 0.8× 250 0.8× 237 4.4k

Countries citing papers authored by Frank Spillmann

Since Specialization
Citations

This map shows the geographic impact of Frank Spillmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Spillmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Spillmann more than expected).

Fields of papers citing papers by Frank Spillmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Spillmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Spillmann. The network helps show where Frank Spillmann may publish in the future.

Co-authorship network of co-authors of Frank Spillmann

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Spillmann. A scholar is included among the top collaborators of Frank Spillmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Spillmann. Frank Spillmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pappritz, Kathleen, Muhammad El‐Shafeey, Henry Fechner, et al.. (2022). Colchicine Prevents Disease Progression in Viral Myocarditis Via Modulating the NLRP3 Inflammasome in the Cardiosplenic Axis. ESC Heart Failure. 9(2). 925–941. 50 indexed citations
2.
Tschöpe, Carsten, Frank Spillmann, T. Gromann, et al.. (2020). Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device. Interactive Cardiovascular and Thoracic Surgery. 31(4). 475–482. 17 indexed citations
3.
Tschöpe, Carsten, Alessio Alogna, Alessandro Faragli, et al.. (2020). Case Report First-in-Man Method Description: Left Ventricular Unloading With iVAC2L During Veno-Arterial Extracorporeal Membrane Oxygenation: From Veno-Arterial Extracorporeal Membrane Oxygenation to ECMELLA to EC-iVAC®. Frontiers in Cardiovascular Medicine. 7. 563448–563448. 8 indexed citations
4.
Tschöpe, Carsten, Sophie Van Linthout, Sebastian Jäger, et al.. (2020). Modulation of the Acute Defence Reaction by Eplerenone Prevents Cardiac Disease Progression in Viral Myocarditis. ESC Heart Failure. 7(5). 2838–2852. 15 indexed citations
5.
Tschöpe, Carsten, Behrouz Kherad, Oliver Klein, et al.. (2018). Cardiac Contractility Modulation: Mechanisms of Action in Heart Failure with Reduced Ejection Fraction and Beyond. European Journal of Heart Failure. 21(1). 14–22. 70 indexed citations
6.
Spillmann, Frank, Uwe Kühl, Sophie Van Linthout, et al.. (2015). Reversible Transition from a Hypertrophic to a Dilated Cardiomyopathy. ESC Heart Failure. 3(2). 138–142. 2 indexed citations
7.
Spillmann, Frank, Sophie Van Linthout, & Carsten Tschöpe. (2012). Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy. Endocrine Metabolic & Immune Disorders - Drug Targets. 12(2). 132–147. 14 indexed citations
8.
Meloni, Marco, Andrea Caporali, Gallia Graiani, et al.. (2010). Nerve Growth Factor Promotes Cardiac Repair following Myocardial Infarction. Circulation Research. 106(7). 1275–1284. 157 indexed citations
9.
Spillmann, Frank, Heinz‐Peter Schultheiss, Carsten Tschöpe, & Sophie Van Linthout. (2010). High-Density Lipoprotein-Raising Strategies: Update 2010. Current Pharmaceutical Design. 16(13). 1517–1530. 11 indexed citations
10.
Linthout, Sophie Van, Anna Foryst‐Ludwig, Frank Spillmann, et al.. (2010). Impact of HDL on adipose tissue metabolism and adiponectin expression. Atherosclerosis. 210(2). 438–444. 71 indexed citations
11.
Westermann, Dirk, Mario Kašner, Paul Steendijk, et al.. (2008). Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction. Circulation. 117(16). 2051–2060. 347 indexed citations
12.
Linthout, Sophie Van, Frank Spillmann, Anna Foryst‐Ludwig, et al.. (2007). Increased high density lipoprotein cholesterol induced by human apolipoprotein A-1 gene transfer increases adiponectin expression in abdominal adipose tissue. Circulation. 116(16). 286–286. 1 indexed citations
13.
Westermann, Dirk, Sophie Van Linthout, Sameer A. Dhayat, et al.. (2007). Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Research in Cardiology. 102(6). 500–507. 180 indexed citations
14.
Riad, A., Thomas Walther, James Yang, et al.. (2007). The cardiovascular influence of interleukin-1β on the expression of bradykinin B1 and B2 receptors. International Immunopharmacology. 8(2). 222–230. 7 indexed citations
15.
Linthout, Sophie Van, A. Riad, Nasser A. Dhayat, et al.. (2007). Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia. 50(9). 1977–1986. 111 indexed citations
16.
Gadau, Sergio Domenico, Costanza Emanueli, Sophie Van Linthout, et al.. (2006). Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia. 49(2). 405–420. 69 indexed citations
17.
Spillmann, Frank, Sophie Van Linthout, Heinz‐Peter Schultheiss, & Carsten Tschöpe. (2005). Cardioprotective mechanisms of the kallikrein–kinin system in diabetic cardiopathy. Current Opinion in Nephrology & Hypertension. 15(1). 22–29. 29 indexed citations
18.
Dorenkamp, Marc, Alexander Riad, Frank Spillmann, et al.. (2005). Protection against oxidative stress in diabetic rats: Role of angiotensin AT1 receptor and beta 1-adrenoceptor antagonism. European Journal of Pharmacology. 520(1-3). 179–187. 32 indexed citations
19.
Spillmann, Frank, Christine Altmann, Marcos Barbosa, et al.. (2002). Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy. International Immunopharmacology. 2(13-14). 1823–1832. 35 indexed citations
20.
Tschöpe, Carsten, Frank Spillmann, Silvia Heringer‐Walther, et al.. (1999). Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction. Immunopharmacology. 44(1-2). 111–117. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026